Company snapshot
Market Cap
$2B
Mid-cap2020 — today
10-Year Price
+7%
2020 — today
52-Week Range
$26.54$42.86
Current $38.59· 74%
Featured in rankings
Most Undervalued Healthcare StocksBest Healthcare GARP StocksMost Undervalued Value StocksMost Undervalued Growth StocksBest GARP Stocks (Growth at a Reasonable Price)GARP Universe
Rankings recomputed after each US market close — see where HRMY stands against peers.
Similar companies
| Company | P/E | Div yield |
|---|---|---|
| ALNYAlnylam Pharmaceuticals, Inc. | 8.8 | — |
| ZTSZoetis Inc. | 13.0 | 2.7% |
| CNCCentene Corporation | 23.5 | — |
| ALCAlcon Inc. | 54.7 | 0.5% |
| RVMDRevolution Medicines, Inc. | -21.5 | — |
| ONCBeOne Medicines Ltd. | 5.1 | — |
| IDXXIDEXX Laboratories, Inc. | 40.8 | — |
| TEVATeva Pharmaceutical Industries Limited | 69.1 | — |
Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.
Valuation in context
P/E ratio
12.5
Below average
Below the 10-year average
Sector median 25.4below sector
P/B ratio
2.3
Historically cheap
Historically cheap relative to the last 10 years
Sector median 2.2in line with sector
EV / EBITDA
6.8
Below average
Below the 10-year average
Sector median 15.7below sector
PEG ratio
0.2
Historically cheap
Historically cheap relative to the last 10 years
Sector median 1.8below sector
FCF Yield
15.7%
Historically high
Historically high relative to the last 10 years
Sector median -12.6%above sector